Singular Genomics News

Singular Genomics | ARS: Annual Report to Security Holders

Apr 18 16:37 ET

Singular Genomics | DEF 14A: Definitive information statements

Apr 18 16:33 ET

Singular Genomics | DEFA14A: Others

Apr 18 16:33 ET

Singular Genomics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 5 16:36 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ropp Sam

Mar 19 17:53 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen

Mar 19 17:53 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.

Mar 19 17:52 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew

Mar 19 17:47 ET

Singular Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 18 16:21 ET

Singular Genomics | 10-K: Annual report

Mar 18 16:16 ET

Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results

Mar 18 16:11 ET

Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eli Glezer(6.6%)

Feb 14 17:50 ET

Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew Spaventa(7.9%)

Feb 14 16:18 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ropp Sam

Feb 13 18:07 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna

Feb 13 18:07 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen

Feb 13 18:06 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.

Feb 13 18:06 ET

Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew

Feb 13 18:06 ET

Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(6.83%),James E. Flynn(6.83%), etc.

Feb 12 17:35 ET

Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Domain Partners IX, L.P.(5.1%),Domain Associates, LLC(Less than 0.1%)

Jan 25 16:26 ET